CATHY BARNES: Open Payments
NPI 1740411164 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 10 payments from 7 companies in 2025. Trend: 2023 $58 · 2024 $75 · 2025 $273
Food & beverage: $203Education: $70
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $119 |
| Genentech USA, Inc. | 2 | $43 |
| Coherus Oncology, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $16 |
| ARRAY BIOPHARMA INC | 1 | $16 |
Products named: LYNPARZA, IMFINZI, LOQTORZI, WELIREG, Itovebi, Polivy, MI CANCER SEEK, LORBRENA.
Industry payments across GA — which companies pay providers there.
